Skip to main content
. 2022 Dec 10;149(1):271–280. doi: 10.1007/s00432-022-04518-9

Fig. 4.

Fig. 4

SC144 suppresses IL-6- and OSM-induced STAT3Y705 phosphorylation in L3.6pl human pancreatic cancer cells. Representative Western blots (a) show that SC144 inhibited IL-6-induced STAT3Y705 phosphorylation in L3.6pl cells in a dose-dependent manner. Densitometry revealed that this inhibition was significant after 24 h of treatment (b) (n = 3–8). SC144 inhibited OSM-induced STAT3Y705 phosphorylation in L3.6pl cells in a dose-dependent manner (c) which was significant after six hours of treatment (d) (n = 4–5); *p < 0.05 versus IL-6, **p < 0.01, ***p < 0.001 versus OSM; ANOVA with Bonferroni-corrected post hoc tests